Oncotarget, a weekly peer-reviewed journal first opened its virtual doors in 2010; it’s first articles were released in may of that same year. While Oncotarget has an extensive and experience board of editors, it is overseen by the two primary editors-in-chief: Mikhail Blagosklonny and Andrei Gudkov. Blagosklonny himself has published over 270 papers in various peer-reviewed journal (including Oncotarget and others), giving the site quite a background with his experience alone.
At the time of this writing, Oncotarget has over 150 single issues in its back catalog, with the majority of those issues containing dozens of articles from subjects ranging from DNA sequencing to better understand cancer to the efficiency of various drugs in direct cancer treatment, giving the side a wide breadth of oncology information.
Dove Press said that to access Oncotarget’s archives you can go to their website at http://www.impactjournals.com/oncotarget and browse to the “Archive” section on the left sidebar, or see the current issue under the same name.
According to Impact Journals, in the archive section you can browse the complete history of Oncotarget’s library of articles in chronological, descending order.
In addition to their powerful site, Oncotarget has a presence on most of the popular social media platforms including Facebook, Twitter, Youtube, Google Plus and LinkedIn.
To access the current listing of all presences on various platform, the easiest method is to go to their homepage at http://www.impactjournals.com/oncotarget/ and click the icons for the various platforms in the upper right-hand corner.
The youtube page especially is a wonderful resource; at this time it covers over 15 interviews with various Oncology experts that go into further detail about their featured papers on Oncotarget.
The rest of the social media platforms provide an excellent place to receiving continuing updates about popular articles and interaction with the rest of the cancer research community.